EdgarLookup

ABVC BIOPHARMA, INC. — POS AM Filings

15 POS AM filings on record

This page lists all POS AM filings submitted to the SEC by ABVC BIOPHARMA, INC. (ABVC), sorted by most recent first. Each row links to the full filing on EdgarLookup. ABVC BIOPHARMA, INC. has filed 15 POS AM documents with the SEC since 2002. To view all SEC filings by ABVC BIOPHARMA, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A AW CERT CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 0001213900-26-035543 Mar 27, 2026
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-047480 May 27, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 0001213900-25-047471 May 27, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 6 TO FORM S-1 0001213900-25-047464 May 27, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-044891 May 16, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-044880 May 16, 2025
POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 0001013762-24-001634 Jul 26, 2024
POS AM POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 0001213900-24-036125 Apr 25, 2024
POS AM POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 0001213900-23-032753 Apr 26, 2023
POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-23-032744 Apr 26, 2023
POS AM POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 0001213900-22-034423 Jun 23, 2022
POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-22-032865 Jun 14, 2022
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-22-032864 Jun 14, 2022
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-21-021784 Apr 15, 2021
POS AM OCIS POST EFFECTIVE AMENDMENT NO 1 TO SB--2 0001137892-03-000076 Aug 21, 2003